Fresenius Medical Care AG (0H9X)
LSE
40.11
-0.21 (-0.52%)
Closed
Aug 25, 2026
Day's Range
40.0240.40
52 wk Range
34.6047.81
Financial Statements - 0H9X - Fresenius Medical Care AG
Revenue
19.62B▲ 1.5%
Net Income
1.19B▲ 60.8%Net Margin 6.1%
EBITDA
3.57B▲ 4.7%
Free Cash Flow
1.76B▲ 4.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 19.62B | 19.33B | 19.45B | 19.39B | 17.61B | 17.85B |
| Cost of Goods | 14.59B | 14.57B | 14.52B | 14.50B | 12.84B | 12.32B |
| Gross Profit | 5.02B | 4.75B | 4.92B | 4.89B | 4.77B | 5.53B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.82B | 1.46B | 1.47B | 1.45B | 1.85B | 2.20B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 212K | -74.98M | -107.20M | 57.02M | -7.23M | 94.51M |
| Pre Tax Income | 1.51B | 1.05B | 1.03B | 1.21B | 1.57B | 1.93B |
| Income Tax | 320.97M | 316.05M | 300.55M | 324.95M | 352.83M | 500.55M |
| Net Income | 1.19B | 740.87M | 732.45M | 894.32M | 1.21B | 1.43B |
| EPS Basic | 3.36 | 1.83 | 1.7 | 2.3 | 3.31 | 3.96 |
| EPS Diluted | 3.36 | 1.83 | 1.7 | 2.3 | 3.31 | 3.96 |
| Basic Shares Outstanding | 291.19M | 293.41M | 293.41M | 293.24M | 292.94M | 294.05M |
| Diluted Shares Outstanding | 291.19M | 293.41M | 293.41M | 293.24M | 292.94M | 294.05M |
| Ebit | 1.89B | 1.46B | 1.45B | 1.57B | 1.92B | 2.34B |
| Ebitda | 3.57B | 3.41B | 3.43B | 3.57B | 3.64B | 4.13B |
| Net Income Continuous Operations | 1.19B | 740.87M | 732.45M | 894.32M | 1.21B | 1.43B |
| Minority Interests | -212.90M | -202.95M | -233.46M | -220.92M | -249.72M | -271.45M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
